Weill David Insider Trading Activity

Average Profitability
16.41%
Insider Buys Quantity
2
Insider Buys Sum
$495,000.00
Insider Sells Quantity
4
Insider Sells Sum
$2.16M

Insider Activity of Weill David

According to the SEC Form 4 filings, Weill David, being in a position of

  1. director at TransMedics Group, Inc.,
    оver the last 12 months, has bought 1336 shares for $109,058, and sold 8571 share for $1.22M,
    over all time since 2019-11-11, has bought 23836 shares for $604,058, and sold 40575 shares for $3.47M.

Biography of Weill David

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $109,058133
Sells
 $1,217,494267

Comparison of Insiders on Amount of Buys and Sells

2026-09-11PurchaseTransMedics Group, Inc.
TMDX
director
1,336
0.0038%
$81.63$109,058-3.87%
2026-03-04SaleTransMedics Group, Inc.
TMDX
director
3,571
0.0104%
$146.82$524,294-45.31%
2025-12-03SaleTransMedics Group, Inc.
TMDX
director
5,000
0.0145%
$138.64$693,200-36.5%
2025-05-23SaleTransMedics Group, Inc.
TMDX
director
732
0.0022%
$123.88$90,680-1.26%
2024-05-29SaleTransMedics Group, Inc.
TMDX
director
1,193
0.0036%
$141.65$168,988-34.94%
2024-05-10SaleTransMedics Group, Inc.
TMDX
director
2,500
0.0076%
$129.82$324,550-28.89%
2023-08-29PurchaseTransMedics Group, Inc.
TMDX
director
2,500
0.0074%
$62.00$155,000+32.05%
2023-02-27SaleTransMedics Group, Inc.
TMDX
director
5,934
0.0181%
$76.69$455,100-4.1%
2022-11-10SaleTransMedics Group, Inc.
TMDX
director
21,645
0.073%
$56.00$1.21M+17.65%
2019-11-11PurchaseTransMedics Group, Inc.
TMDX
director
20,000
0.0954%
$17.00$340,000+0.77%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.